Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 451K 421K 387K 729K 49.47M 742K 4.97M 1.94M 24.67M 1.95M 1.91M 81.37M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.16M 17.89M 16.42M 30.97M 2.1B 31.51M 211M 82.62M 1.05B 82.82M 80.98M 3.46B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/11/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/10/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/10/23	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/09/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/08/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/08/23	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/07/23	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/07/23	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/06/23	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

11-18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/05/24	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/05/24	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/10/23	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/10/23	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-2.39%	-6.36%	+45.82%	+149.66%	1,024B
JOHNSON & JOHNSON	-0.76%	-4.34%	+48.74%	+49.09%	618B
ABBVIE INC.	-2.33%	-4.60%	+24.30%	+64.44%	443B
ROCHE HOLDING AG	+0.68%	+0.25%	+38.47%	+31.95%	349B
NOVARTIS AG	-1.66%	-1.89%	+32.18%	+37.17%	297B
ASTRAZENECA PLC	-8.96%	-9.23%	+3.57%	+3.64%	264B
NOVO NORDISK A/S	-1.37%	-5.71%	-2.10%	-44.43%	209B
AMGEN INC.	-1.63%	+0.69%	+25.48%	+64.23%	208B
GILEAD SCIENCES, INC.	+0.72%	+0.48%	+14.53%	+73.64%	162B
Average	-2.15%	-1.35%	+25.66%	+47.71%	397.08B
Weighted average by Cap.	-1.98%	-2.17%	+33.29%	+70.34%

Exactus Inc Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

	2022	2023
Net sales	1.63M 1.41M 1.32M 1.21M 2.29M 155M 2.32M 15.57M 6.1M 77.33M 6.11M 5.98M 255M	2.38M 2.07M 1.94M 1.78M 3.35M 227M 3.41M 22.82M 8.94M 113M 8.96M 8.76M 374M
Net income	-9.14M -7.95M -7.42M -6.81M -12.84M -871M -13.06M -87.47M -34.26M -435M -34.34M -33.58M -1.43B	-8.02M -6.97M -6.5M -5.97M -11.26M -764M -11.45M -76.69M -30.03M -381M -30.11M -29.44M -1.26B
Net Debt	17.85M 15.52M 14.49M 13.3M 25.08M 1.7B 25.51M 171M 66.9M 849M 67.06M 65.58M 2.8B	21.53M 18.71M 17.47M 16.04M 30.24M 2.05B 30.77M 206M 80.67M 1.02B 80.87M 79.08M 3.38B